Authors
Loading...
Randomized trial reveals immune–metabolic diversity in colorectal cancer subtypes, suggesting refined therapeutic strategies.
Madurga et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: